Furthermore, we compared the therapeutic potential of MSCs and fibroblasts in a novel treatment strategy where mice with CCL4‐induced fibrosis and cirrhosis underwent a partial hepatectomy (pHx), as regeneration stimulus, and received concomitant cell therapy. This evidence concerns the gene CCL4 and Cirrhosis.